77/100
High Financial Strength
31/100
Mid Valuation
44/100
Technically Neutral
Strength
6
Weakness
4
Opportunity
0
Threats
0
Market Cap (Cr)
PE Ratio
Price to Book Ratio
RSI
Net Profit Margin
Board Meeting Intimation for Consideration And Approval Of The Audited Financial Results For The Quarter / Financial Year Ended March 31 2025 And To Discuss The Matter Of Recommendation Of Dividend If Any For The Financial Year Ended March 31 2025
3B Blackbio Dx Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/05/2025 inter alia to consider and approve the Audited Financial Results (Standalone and Consolidated) for the quarter /financial year ended March 31 2025... More>
Intimation To The Holders Of Physical Securities To Furnish KYC Details
Intimation to the holders of Physical Securities to furnish KYC details
Intimation Under Regulation 30 Of SEBI (LODR) Regulations 2015
Intimation under Regulation 30 of SEBI (LODR) Regulations 2015
Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2
Format of the Annual Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1 Name of Company 3B BlackBio Dx Ltd 2 CIN NO. L24211MP1972PLC001131 ... More>
COMPLIANCE CERTIFICATE UNDER REGULATION 40(9) OF SEBI (LODR) REGULATIONS 2015 FOR THE YEAR ENDED 31-03-2025.
Compliance Certificate under Reg 40(9) of SEBI (LODR) Regulations 2015 for the year ended 31-03-2025
Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1Name of Company3B BlackBio Dx Ltd 2CIN NO.L24211MP1972PLC001131 3 Outstanding borrowing of company as on 31st March / 31st December as applicable (in Rs... More>
Non Applicability Of Statement Of Deviation Or Variation Under Reg. 32(1) Of SEBI (LODR) Regulations 2015
Non-Applicability of Statement of Deviation or variation under Reg. 32 (1) of SEBI (LODR) Regulations 2015
Disclosure Under Regulation 31(4) Of SEBI (SAST) Regulations 2011
Disclosure Under Regulation 31(4) of SEBI (SAST) Regulations 2011
Closure of Trading Window
Closure of Trading Window
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Mahesh Kumar Upadhyay
Disclosure Under Regulation 29(2) Of SEBI (SAST) Regulations 2011
Disclosure under Regulation 29(2) of SEBI (SAST) Regulations 2011
Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper Advertisement
Announcement under Regulation 30 (LODR)-Dividend Updates
Dividend updates
Reg. 34 (1) Annual Report.
Annual Report for the FY 2023-24
Notice Of 52Nd Annual General Meeting To Be Held On 24Th September2024
Notice of 52nd Annual General meeting to be held on 24th September 2024
52Nd Annual General Meeting On Tuesday 24Th September 2024
52nd Annual General Meeting on Tuesday 24th September 2024
Record Date And Date Of Book Closure For The Purpose Of Dividend And AGM
Record Date and date of Book Closure for the purpose of Dividend and AGM
Shareholders Update
Shareholders Update
Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper Publication
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Schedule of Analyst / Investor meet - Outcome
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation of issue of duplicate share certificate under Reg 39 (3) of SEBI (LODR) Regulations 2015
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Schedule of Analyst / Investor meet - Outcome
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Schedule of Analyst / Investor meet - Outcome
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Schedule of Analyst / Investor meet - Outcome
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation regarding loss of share certificate under Reg 39(3) of SEBI (LODR) Regulations 2015
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Schedule of Analysts / Institutional Investors meet(s) - Intimation
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Schedule of Analysts / Institutional Investors meet(s) - Intimation
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Schedule of Analysts / Institutional Investors meet(s) - Intimation
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Schedule of Analysts / Institutional Investors meet(s) - Intimation
Announcement under Regulation 30 (LODR)-Newspaper Publication
Submission of Advertisement Clipping of Extract of the Unaudited Standalone and Consolidated Financial Results for the quarter ended 30-06-2024
Unaudited Standalone And Consolidated Financial Results For Quarter Ended 30-06-24
Unaudited Standalone and Consolidated Financial Results for quarter ended 30-06-24
Board Meeting Outcome for Outcome Of Board Meeting Dt 12-08-2024
Outcome of Board Meeting dt 12-08-2024
Intimation Of Notice To Shareholders For Transfer Of Equity Shares To The Investor Education And Pro
Intimation of Notice to Shareholders for transfer of Equity Shares to the Investor Education and Protection Fund (IEPF) Authority.
Announcement under Regulation 30 (LODR)-Investor Presentation
Investors Presentation
Announcement under Regulation 30 (LODR)-Newspaper Publication
Disclosure under Regulation 30 of SEBI (LODR) Regulations2015-Newspaper Publication
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation of issue of Duplicate Share Certificate under Reg 39(3) of SEBI (LODR) Regulations 2015
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation regarding loss of share certificate under Reg 39(3) of SEBI (LODR) Regulations 2015
Board Meeting Intimation for Consideration And Approval Of Unaudited Standalone And Consolidated Fin
3B Blackbio Dx Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2024 inter alia to consider and approve the unaudited Standalone and Consolidated Financial Results of the company for the first quarter ended on 30th... More>
Intimation To Holders Of Physical Securities To Furnish PAN KYC Details And Nomination As Per SEBI C
Intimation to holders of physical securities to furnish PANKYC details and Nomination as per SEBI Circular
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
Certificate under Reg 74(5) of SEBI (DP) Regulations2018
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation of issue of Duplicate Share Certificate under Reg 39(3) of SEBI (LODR) Regulations 2015
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Details of Loss of Certificate/Duplicate Certificate
Closure of Trading Window
Closure of Trading Window
Clarification On Price Movement
Clarification on Price Movement
Clarification sought from 3B BlackBio Dx Ltd
The Exchange has sought clarification from 3B BlackBio Dx Ltd on June 12 2024 with reference to significant movement in price in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the... More>
Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper Publication of Extract of Audited Financial Results for quarter and year ended 31-03-2024
Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper Publication of Extract of Audited Financial Results for the quarter and year ended 31-03-2024
Submission Of Audited Financial Results Of The Company For The Quarter And Financial Year Ended 31 M
Submission of Audited Financial Results for the Quarter and Financial Year ended 31st March2024
Board Meeting Outcome for Outcome Of BM
Outcome of BM
Announcement under Regulation 30 (LODR)-Dividend Updates
Dividend update
Announcement under Regulation 30 (LODR)-Dividend Updates
Dividend update
Board Meeting Outcome for Outcome Of BM
Outcome of BM
Investor Presentation
Investor Presentation
Compliances-Reg.24(A)-Annual Secretarial Compliance
Annual Secretarial Compliance Report for the year ended 31-03-2024.
Intimation Under Regulation 30 Of The SEBI (LODR) Regulations 2015.
Intimation under Regulation 30 of the SEBI (LODR) Regulations 2015.
Board Meeting Intimation for Consideration And Approval Of Audited Financial Results (Standalone And
3B Blackbio Dx Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2024 inter alia to consider and approve the Audited Financial Results (Standalone and Consolidated) for the quarter / year ended March 31 2024 .
Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2
Format of the Annual Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1 Name of Company 3B BlackBio Dx Ltd 2 CIN NO. L24211MP1972PLC001131 ... More>
Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure
Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1Name of Company3B BlackBio Dx Ltd 2CIN NO.L24211MP1972PLC001131 3 Outstanding borrowing of company as on 31st March / 31st December as applicable (in Rs... More>
Submission Of Compliance Certificate Under Regulation 40(9) Of The SEBI (LODR) Regulations 2015 For
Submission of compliance certificate under Regulation 40(9) of the SEBI (LODR) Regulations 2015 for the financial year ended 31-03-2024
Disclosure Under Reg 32(1) Of SEBI (LODR) Regulations2015
Disclosure under Reg 32(1) of SEBI (LODR) Regualtions2015
Compliance Certificate- Regulation 7(3) OF SEBI (LODR) Regulations 2015.
Compliance Certificate - Regulation 7 (3) of SEBI (LODR) Regulations 2015
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
Certificate under Reg. 74 (5) of the SEBI (DP) Regulations 2018
Disclosure Under Regulation 31(4) Of SEBI (SAST) Regulations 2011
Disclosure Under Regulation 31(4) of SEBI (SAST) Regulations 2011
Closure of Trading Window
Closure of Trading Window
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation of issue of Duplicate share certificate under Reg 39(3) of SEBI (LODR) Regulations 2015
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation regarding Loss of Share Certificates under Regulation 39(3) of SEBI (LODR) 2015
Announcement under Regulation 30 (LODR)-Newspaper Publication
Submission of Advertisement Clipping of Extract of the Unaudited Standalone and Consolidated Financial Results for the quarter and nine months ended 31st December2023.
Investors Presentation
Investors Presentation
Unaudited Financial Results For The Quarter And Nine Months Ended 31St December 2023.
Unaudited Financial Results for the Quarter and Nine Months Ended 31st December2023
Board Meeting Outcome for Outcome Of The Board Meeting- Unaudited Financial Results For The Quarter
Outcome Of The Board Meeting- Unaudited Financial Results For The Quarter And Nine Months Ended 31st December 2023.
Board Meeting Intimation for Consideration And Approval Of Unaudited Standalone And Consolidated Fin
3B Blackbio Dx Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/02/2024 inter alia to consider and approve the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and nine months ended... More>
Business Update
Business Update
Board Meeting Intimation for Consideration And Approval Of The Audited Financial Results For The Quarter / Financial Year Ended March 31 2025 And To Discuss The Matter Of Recommendation Of Dividend If Any For The Financial Year Ended March 31 2025
3B Blackbio Dx Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/05/2025 inter alia to consider and approve the Audited Financial Results (Standalone and Consolidated) for the quarter /financial year ended March 31 2025 and to discuss the matter of recommendation of dividend if any for the financial year ended March 31 2025
Intimation To The Holders Of Physical Securities To Furnish KYC Details
Intimation to the holders of Physical Securities to furnish KYC details
Intimation Under Regulation 30 Of SEBI (LODR) Regulations 2015
Intimation under Regulation 30 of SEBI (LODR) Regulations 2015
Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2
Format of the Annual Disclosure to be made by an entity identified as a Large Corporate.
Sr. No. | Particulars | Details |
1 | Name of Company | 3B BlackBio Dx Ltd |
2 | CIN NO. | L24211MP1972PLC001131 |
3 | Report filed for FY | 2024-2025 |
Details of the Current block (all figures in Rs crore): | ||
4 | 2 - year block period (Specify financial years)* | NA |
5 | Incremental borrowing done in FY (T)(a) | 0.00 |
6 | Mandatory borrowing to be done through debt securities in FY (T) (b) = (25% of a) | 0.00 |
7 | Actual borrowing done through debt securities in FY (T)(c) | 0.00 |
8 | Shortfall in the borrowing through debt securities if any for FY (T - 1) carried forward to FY (T) (d) | 0 |
8 | Quantum of (d) which has been met from (c)(e)* | 0 |
9 | Shortfall if any in the mandatory borrowing through debt securities for FY (T) { after adjusting for any shortfall in borrowing for FY(T - 1) which was carried forward to FY(T)}(f) = (b) - [(c) - (e)]{ If the calculated value is zero or negative write nil}* | 0 |
Details of penalty to be paid if any in respect to previous block (all figures in Rs crore): | |
2 - year Block period (Specify financial years) | NA |
Amount of fine to be paid for the block if applicable Fine = 0.2% of {(d) - (e)}# | 0.00 |
Name of the Company Secretary :- | Navneet Kaur |
Designation :- | Company Secretary |
Name of the Chief Financial Officer :- | Nikhil Kuber Dubey |
Designation : - | CFO and Whole Time Director |
COMPLIANCE CERTIFICATE UNDER REGULATION 40(9) OF SEBI (LODR) REGULATIONS 2015 FOR THE YEAR ENDED 31-03-2025.
Compliance Certificate under Reg 40(9) of SEBI (LODR) Regulations 2015 for the year ended 31-03-2025
Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
Format of Initial Disclosure to be made by an entity identified as a Large Corporate.
Sr. No. | Particulars | Details |
1 | Name of Company | 3B BlackBio Dx Ltd |
2 | CIN NO. | L24211MP1972PLC001131 |
3 | Outstanding borrowing of company as on 31st March / 31st December as applicable (in Rs cr) | 0.31 |
4 | Highest Credit Rating during the previous FY | NA |
4a | Name of the Credit Rating Agency issuing the Credit Rating mentioned in (4) | Not Applicable |
5 | Name of Stock Exchange# in which the fine shall be paid in case of shortfall in the required borrowing under the framework | BSE |
Non Applicability Of Statement Of Deviation Or Variation Under Reg. 32(1) Of SEBI (LODR) Regulations 2015
Non-Applicability of Statement of Deviation or variation under Reg. 32 (1) of SEBI (LODR) Regulations 2015
Disclosure Under Regulation 31(4) Of SEBI (SAST) Regulations 2011
Disclosure Under Regulation 31(4) of SEBI (SAST) Regulations 2011
Closure of Trading Window
Closure of Trading Window
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Mahesh Kumar Upadhyay
Disclosure Under Regulation 29(2) Of SEBI (SAST) Regulations 2011
Disclosure under Regulation 29(2) of SEBI (SAST) Regulations 2011
Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper Advertisement
Announcement under Regulation 30 (LODR)-Dividend Updates
Dividend updates
Reg. 34 (1) Annual Report.
Annual Report for the FY 2023-24
Notice Of 52Nd Annual General Meeting To Be Held On 24Th September2024
Notice of 52nd Annual General meeting to be held on 24th September 2024
52Nd Annual General Meeting On Tuesday 24Th September 2024
52nd Annual General Meeting on Tuesday 24th September 2024
Record Date And Date Of Book Closure For The Purpose Of Dividend And AGM
Record Date and date of Book Closure for the purpose of Dividend and AGM
Shareholders Update
Shareholders Update
Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper Publication
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Schedule of Analyst / Investor meet - Outcome
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation of issue of duplicate share certificate under Reg 39 (3) of SEBI (LODR) Regulations 2015
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Schedule of Analyst / Investor meet - Outcome
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Schedule of Analyst / Investor meet - Outcome
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Schedule of Analyst / Investor meet - Outcome
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation regarding loss of share certificate under Reg 39(3) of SEBI (LODR) Regulations 2015
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Schedule of Analysts / Institutional Investors meet(s) - Intimation
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Schedule of Analysts / Institutional Investors meet(s) - Intimation
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Schedule of Analysts / Institutional Investors meet(s) - Intimation
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Schedule of Analysts / Institutional Investors meet(s) - Intimation
Announcement under Regulation 30 (LODR)-Newspaper Publication
Submission of Advertisement Clipping of Extract of the Unaudited Standalone and Consolidated Financial Results for the quarter ended 30-06-2024
Unaudited Standalone And Consolidated Financial Results For Quarter Ended 30-06-24
Unaudited Standalone and Consolidated Financial Results for quarter ended 30-06-24
Board Meeting Outcome for Outcome Of Board Meeting Dt 12-08-2024
Outcome of Board Meeting dt 12-08-2024
Intimation Of Notice To Shareholders For Transfer Of Equity Shares To The Investor Education And Pro
Intimation of Notice to Shareholders for transfer of Equity Shares to the Investor Education and Protection Fund (IEPF) Authority.
Announcement under Regulation 30 (LODR)-Investor Presentation
Investors Presentation
Announcement under Regulation 30 (LODR)-Newspaper Publication
Disclosure under Regulation 30 of SEBI (LODR) Regulations2015-Newspaper Publication
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation of issue of Duplicate Share Certificate under Reg 39(3) of SEBI (LODR) Regulations 2015
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation regarding loss of share certificate under Reg 39(3) of SEBI (LODR) Regulations 2015
Board Meeting Intimation for Consideration And Approval Of Unaudited Standalone And Consolidated Fin
3B Blackbio Dx Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2024 inter alia to consider and approve the unaudited Standalone and Consolidated Financial Results of the company for the first quarter ended on 30th June2024
Intimation To Holders Of Physical Securities To Furnish PAN KYC Details And Nomination As Per SEBI C
Intimation to holders of physical securities to furnish PANKYC details and Nomination as per SEBI Circular
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
Certificate under Reg 74(5) of SEBI (DP) Regulations2018
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation of issue of Duplicate Share Certificate under Reg 39(3) of SEBI (LODR) Regulations 2015
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Details of Loss of Certificate/Duplicate Certificate
Closure of Trading Window
Closure of Trading Window
Clarification On Price Movement
Clarification on Price Movement
Clarification sought from 3B BlackBio Dx Ltd
The Exchange has sought clarification from 3B BlackBio Dx Ltd on June 12 2024 with reference to significant movement in price in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded.
The reply is awaited.
Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper Publication of Extract of Audited Financial Results for quarter and year ended 31-03-2024
Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper Publication of Extract of Audited Financial Results for the quarter and year ended 31-03-2024
Submission Of Audited Financial Results Of The Company For The Quarter And Financial Year Ended 31 M
Submission of Audited Financial Results for the Quarter and Financial Year ended 31st March2024
Board Meeting Outcome for Outcome Of BM
Outcome of BM
Announcement under Regulation 30 (LODR)-Dividend Updates
Dividend update
Announcement under Regulation 30 (LODR)-Dividend Updates
Dividend update
Board Meeting Outcome for Outcome Of BM
Outcome of BM
Investor Presentation
Investor Presentation
Compliances-Reg.24(A)-Annual Secretarial Compliance
Annual Secretarial Compliance Report for the year ended 31-03-2024.
Intimation Under Regulation 30 Of The SEBI (LODR) Regulations 2015.
Intimation under Regulation 30 of the SEBI (LODR) Regulations 2015.
Board Meeting Intimation for Consideration And Approval Of Audited Financial Results (Standalone And
3B Blackbio Dx Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2024 inter alia to consider and approve the Audited Financial Results (Standalone and Consolidated) for the quarter / year ended March 31 2024 .
Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2
Format of the Annual Disclosure to be made by an entity identified as a Large Corporate.
Sr. No. | Particulars | Details |
1 | Name of Company | 3B BlackBio Dx Ltd |
2 | CIN NO. | L24211MP1972PLC001131 |
3 | Report filed for FY | 2023-2024 |
Details of the Current block (all figures in Rs crore): | ||
4 | 2 - year block period (Specify financial years)* | 0 |
5 | Incremental borrowing done in FY (T)(a) | 0.00 |
6 | Mandatory borrowing to be done through debt securities in FY (T) (b) = (25% of a) | 0.00 |
7 | Actual borrowing done through debt securities in FY (T)(c) | 0.00 |
8 | Shortfall in the borrowing through debt securities if any for FY (T - 1) carried forward to FY (T) (d) | 0 |
8 | Quantum of (d) which has been met from (c)(e)* | 0 |
9 | Shortfall if any in the mandatory borrowing through debt securities for FY (T) { after adjusting for any shortfall in borrowing for FY(T - 1) which was carried forward to FY(T)}(f) = (b) - [(c) - (e)]{ If the calculated value is zero or negative write nil}* | 0 |
Details of penalty to be paid if any in respect to previous block (all figures in Rs crore): | |
2 - year Block period (Specify financial years) | 0 |
Amount of fine to be paid for the block if applicable Fine = 0.2% of {(d) - (e)}# | 0.00 |
Name of the Company Secretary :- | Navneet Kaur |
Designation :- | Company Secretary |
Name of the Chief Financial Officer :- | Nikhil Kuber Dubey |
Designation : - | CFO and WholeTime Director |
Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure
Format of Initial Disclosure to be made by an entity identified as a Large Corporate.
Sr. No. | Particulars | Details |
1 | Name of Company | 3B BlackBio Dx Ltd |
2 | CIN NO. | L24211MP1972PLC001131 |
3 | Outstanding borrowing of company as on 31st March / 31st December as applicable (in Rs cr) | 0.71 |
4 | Highest Credit Rating during the previous FY | NA |
4a | Name of the Credit Rating Agency issuing the Credit Rating mentioned in (4) | Not Applicable |
5 | Name of Stock Exchange# in which the fine shall be paid in case of shortfall in the required borrowing under the framework | BSE |
Submission Of Compliance Certificate Under Regulation 40(9) Of The SEBI (LODR) Regulations 2015 For
Submission of compliance certificate under Regulation 40(9) of the SEBI (LODR) Regulations 2015 for the financial year ended 31-03-2024
Disclosure Under Reg 32(1) Of SEBI (LODR) Regulations2015
Disclosure under Reg 32(1) of SEBI (LODR) Regualtions2015
Compliance Certificate- Regulation 7(3) OF SEBI (LODR) Regulations 2015.
Compliance Certificate - Regulation 7 (3) of SEBI (LODR) Regulations 2015
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
Certificate under Reg. 74 (5) of the SEBI (DP) Regulations 2018
Disclosure Under Regulation 31(4) Of SEBI (SAST) Regulations 2011
Disclosure Under Regulation 31(4) of SEBI (SAST) Regulations 2011
Closure of Trading Window
Closure of Trading Window
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation of issue of Duplicate share certificate under Reg 39(3) of SEBI (LODR) Regulations 2015
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation regarding Loss of Share Certificates under Regulation 39(3) of SEBI (LODR) 2015
Announcement under Regulation 30 (LODR)-Newspaper Publication
Submission of Advertisement Clipping of Extract of the Unaudited Standalone and Consolidated Financial Results for the quarter and nine months ended 31st December2023.
Investors Presentation
Investors Presentation
Unaudited Financial Results For The Quarter And Nine Months Ended 31St December 2023.
Unaudited Financial Results for the Quarter and Nine Months Ended 31st December2023
Board Meeting Outcome for Outcome Of The Board Meeting- Unaudited Financial Results For The Quarter
Outcome Of The Board Meeting- Unaudited Financial Results For The Quarter And Nine Months Ended 31st December 2023.
Board Meeting Intimation for Consideration And Approval Of Unaudited Standalone And Consolidated Fin
3B Blackbio Dx Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/02/2024 inter alia to consider and approve the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and nine months ended 31st December 2023.
Business Update
Business Update